Pharmaceutical

GSK CEO addresses declining trust in vaccines following Trump re-election

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to gauge impact.

Nov 7, 2024 - 06:00
GSK CEO addresses declining trust in vaccines following Trump re-election
GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to gauge impact.
Read the original article

Tags:

Previous Article

Strong Wegovy revenue growth for Novo Nordisk but shares dip

Next Article

Tevogen Bio partners Microsoft for HPV treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA scolds Novartis over a misleading TV ad for a breast cancer treatment

STAT+: FDA scolds Novartis over a misleading TV ad for ...

Jan 20, 2024

Bristol-Myers Squibb sees highest patent filings and grants during August in Q3 2023

Bristol-Myers Squibb sees highest patent filings and gr...

Nov 24, 2023

Japan grants patent for BioArctic’s Parkinson’s disease antibody

Japan grants patent for BioArctic’s Parkinson’s disease...

Aug 24, 2023